Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Jun. 30, 2019
Current assets:    
Cash $ 110,101 $ 30,142
Accounts receivable - net 50,924 45,086
Inventories 285,879 406,439
Other current assets 580,746 1,000
Total current assets 1,027,650 482,667
Total assets 1,027,650 482,667
Current liabilities:    
Accounts payable 1,213,649 496,809
Accrued expense-related party 9,974 33,974
Short term borrowings - line of credit 5,000
Convertible notes payable - net of discount 1,790,578 1,117,741
Fair value of derivative liabilities 1,598,539 1,306,748
Total current liabilities 4,617,740 2,955,272
Commitments and contingencies
Stockholders' deficit:    
Preferred stock, ($0.001 par value, 100,000,000 shares authorized, and 1,000 issued and outstanding as of March 31, 2020 and 1,000 outstanding as of June 30, 2019, respectively) 1 1
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 60,189,966 issued and outstanding as of March 31, 2020 and 53,773,856 outstanding as of June 30, 2019, respectively) 60,190 53,774
Additional paid in capital 12,310,827 10,692,679
Accumulated deficit (15,961,108) (13,219,059)
Total stockholders' deficit (3,590,090) (2,472,605)
Total Liabilities and Stockholders' Deficit $ 1,027,650 $ 482,667